Abstract

Nitric oxide (NO) is a powerful antiplatelet agent, but its notoriously short biological half-life limits its potential to prevent the activation of circulating platelets. Here we used diethylamine diazeniumdiolate (DEA/NO) as an NO generator to determine whether the antiplatelet effects of NO are prolonged by the formation of a durable, plasma-borne S-nitrosothiol reservoir. Preincubation of both platelet rich plasma (PRP) and washed platelets (WP) with DEA/NO (2 microm) for 1 min inhibited collagen-induced platelet aggregation by 82 +/- 5 and 91 +/- 2%, respectively. After 30 min preincubation with DEA/NO, NO was no longer detectable in either preparation, but aggregation remained markedly inhibited (72 +/- 7%) in PRP. In contrast, the inhibitory effect in WP was almost completely lost at this time (5 +/- 3%) but was partially restored (39 +/- 10%) in WP containing human serum albumin (1%) and fully restored by co-incubation with albumin and the low molecular weight (LMW) thiols, glutathione, (5 microm), cysteinyl-glycine (10 microm), or cysteine (10 microm). This NO-mediated effect was not seen with LMW thiols in the absence of albumin and was associated with S-nitrosothiol formation. Our results demonstrate that LMW thiols play an important role in both the formation and activation of an S-nitrosoalbumin reservoir that significantly prolongs the duration of action of NO.

Highlights

  • Nitric oxide (NO)1 is a crucial free radical messenger with potent antiplatelet activity [1,2,3,4,5]

  • Addition of 2 ␮M DEA/NO to washed platelets (WP) reconstituted with 0.46 ␮M hemoglobin derived from donor red blood cell (RBC) lysate produced a profile matching that observed in platelet rich plasma (PRP) with a maximum extracellular NO concentration of 0.59 Ϯ 0.05 ␮M (n ϭ 6)

  • Our results clearly demonstrate that the biological activity of DEA/NO, a short-acting NO-donor drug with a half-life of ϳ2 min at physiological temperature and pH, is significantly prolonged in PRP compared with WP, where activity closely mirrored NO concentration

Read more

Summary

Introduction

Nitric oxide (NO)1 is a crucial free radical messenger with potent antiplatelet activity [1,2,3,4,5]. We explored the hypothesis that low molecular weight thiols have a unique role in both the formation and activation of an S-nitrosoalbumin reservoir, potentiating NO-mediated inhibition of platelet aggregation. Inhibition of platelet aggregation by DEA/NO at 30 min in the presence of HSA and GSH was partially quenched by preincubation of 0.46 ␮M RBC-derived hemoglobin in WP (p Ͻ 0.01), inhibition was still significantly enhanced when compared with WP alone (Fig. 4; n ϭ 8).

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.